Articles

Novel Agents in CML Therapy:Tyrosine Kinase Inhibitors and Beyond-Junia V. Melo;Charles Chuah

Posted on Friday, December 12, 2008 - 3:34pm

Novel Agents in CML Therapy: Tyrosine Kinase Inhibitors and Beyond Junia V. Melo (2) and Charles Chuah (1)

Read more

IRIS data- 86 Percent of Patients With Ph+ CML alive after 7 years

Posted on Friday, December 12, 2008 - 12:44pm

Press Release Source: Novartis Pharmaceuticals UK Ltd Data Shows Longest Ever Survival for Patients With Life-Threatening Leukaemia Treated With Breakthrough Treatment Monday December 8, 5:00 pm ET - 86 Percent of...

Read more

Why TKI's Control, but do not eradicate Leukemia

Posted on Friday, December 12, 2008 - 12:32pm

Why Gleevec-type Drugs Control, But Do Not Eradicate, Leukemia ScienceDaily (Dec. 11, 2008) — Oregon Health & Science University Knight Cancer Institute researchers are closer to understanding why certain chronic...

Read more

OHSU pre-clinical study finds that a combination of SGX393 with either Sprycel or Tasigna completely suppressed resistance

Posted on Friday, December 12, 2008 - 12:27pm

New Approach To Help Control Drug Resistance In Leukemia Identified ScienceDaily (Mar. 25, 2008) — Oregon Health & Science University Cancer Institute researchers have found that an experimental drug known as SGX393...

Read more

Combination Of Two Novel Anti-cancer Agents May Help Fight CML Resistant To Current Therapy

Posted on Friday, December 12, 2008 - 12:20pm

Combination Of Two Novel Anti-cancer Agents May Help Fight CML Resistant To Current Therapy ScienceDaily (June 1, 2008) — Virginia Commonwealth University Massey Cancer Center researchers have identified that a...

Read more

MK-0457 active against T315I mutation in CML ALL and JAK2 mutation in MPD

Posted on Friday, December 12, 2008 - 12:14pm

Drug Shown To Be Clinically Active Against Multiple Target Mutations In Two Types Of Leukemia And Myeloproliferative Disorders ScienceDaily (Dec. 21, 2006) — Researchers at The University of Texas M. D. Anderson Cancer...

Read more

Vaccine Improves Event-free Survival For Leukemia Patients

Posted on Friday, December 12, 2008 - 12:07pm

Vaccine Improves Event-free Survival For Leukemia Patients ScienceDaily (Dec. 11, 2007) — Patients whose immune system responded to a peptide vaccine for leukemia enjoyed a median remission that was more than three...

Read more

Dasatinib and nilotinib show strong early results as frontline therapy for CML.

Posted on Friday, December 12, 2008 - 12:03pm

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For Chronic Myelogenous Leukemia ScienceDaily (Dec. 10, 2007) — Two drugs approved for use as second line therapy for chronic myelogenous leukemia are...

Read more

House of Commons-Hansard Debates Nov. 4th 08- NHS Patients (Access to Medicines)

Posted on Friday, November 28, 2008 - 11:50am

4 Nov 2008 : Column 131 NHS Patients (Access to Medicines) 4.7 pm

Read more

EUTOS- European Treatment Outcome Study

Posted on Wednesday, November 26, 2008 - 7:56pm

EUTOS.

Read more

Combating Progressive Disease by Monitoring and Early Detection: War and PCR

Posted on Sunday, November 9, 2008 - 1:51pm

NCCN 3rd Annual Congress: Hematologic Malignancies -- Chronic Myelogenous Leukemia Combating Progressive Disease by Monitoring and Early Detection: War and PCR (Slides with Transcript) Jerald P. Radich, MD...

Read more